Brain Structure, Neurotransmitters, and Behavior (7A)
Help Questions
MCAT Psychological and Social Foundations › Brain Structure, Neurotransmitters, and Behavior (7A)
Researchers investigated histamine signaling and wakeful exploration. In a randomized trial, 64 participants received either a first-generation H1 antihistamine or placebo before completing a virtual-environment exploration task that required learning the locations of novel objects. The behavioral outcomes were total distance explored and later recognition accuracy for object locations. fMRI focused on posterior parietal cortex (PPC) during exploration and hippocampus during retrieval. The antihistamine reduced PPC activation during exploration and reduced total distance explored, while hippocampal activation during retrieval was not significantly different after controlling for exploration time. Which outcome is most consistent with the observed neurotransmitter effects?
Greater exploration and better location recognition due to increased histaminergic arousal under H1 blockade
Reduced exploration with secondary reductions in location learning, consistent with diminished histamine-mediated arousal impacting PPC-guided exploration
No change in exploration because histamine primarily modulates spinal reflexes rather than cortical attention networks
Improved location recognition because H1 blockade selectively enhances hippocampal long-term potentiation during retrieval
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Histamine promotes wakefulness and arousal, with H1 receptors mediating cortical activation necessary for exploration and attention. In this vignette, H1 blockade reduces posterior parietal cortex (PPC) activation during exploration, affecting spatial behavior. Choice B is correct because it accurately reflects how diminished histamine-mediated arousal impairs PPC-guided exploration, leading to reduced exploration and secondary effects on location learning. Choice A is incorrect because H1 blockade reduces, not increases, histaminergic arousal. When analyzing antihistamine effects, consider that first-generation H1 blockers reduce cortical arousal and attention, impairing exploratory behavior and subsequent learning dependent on that exploration.
In a within-subject study, 28 participants received either a nicotinic acetylcholine receptor (nAChR) partial agonist or placebo before performing a sustained attention task with infrequent targets. EEG was recorded, and source localization emphasized right dorsolateral prefrontal cortex (dlPFC). The partial agonist increased target-evoked P300 amplitude and increased dlPFC source strength; behaviorally, hit rate increased with minimal change in false alarms. Which outcome is most consistent with the observed neurotransmitter and brain-structure effects?
No behavioral change because acetylcholine primarily affects amygdala-mediated fear conditioning rather than attention
Increased hit rate due to enhanced cholinergic modulation of dlPFC networks supporting sustained attention
Increased false alarms due to selective inhibition of GABA receptors in the cerebellum
Decreased hit rate due to reduced dlPFC engagement following nAChR stimulation
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Nicotinic acetylcholine receptors (nAChRs) enhance attentional processing, particularly in prefrontal cortical networks like the dorsolateral PFC (dlPFC). In this vignette, nAChR partial agonism increases dlPFC activity and P300 amplitude during target detection. Choice B is correct because it accurately reflects how enhanced cholinergic modulation of dlPFC networks improves sustained attention, leading to increased hit rates. Choice A is incorrect because nAChR stimulation enhances, not reduces, dlPFC engagement. When analyzing cholinergic effects on attention, remember that nicotinic receptor activation typically enhances prefrontal cortical function and improves attentional performance.
A pharmacology experiment tested a selective $$-adrenergic receptor antagonist administered before a public-speaking stressor in 50 adults. Salivary alpha-amylase (an index correlated with sympathetic noradrenergic activation) and self-reported state anxiety were collected, and fMRI measured activity in the locus coeruleus (LC) and medial prefrontal cortex (mPFC) during anticipation. The antagonist reduced alpha-amylase and reduced LC activity, while mPFC activation during anticipation increased relative to placebo. Which behavior change is most consistent with the described neurotransmitter modulation and regional activity pattern?
Higher state anxiety due to increased LC activity and reduced mPFC engagement during anticipation
No change in anxiety because $$-adrenergic receptors primarily mediate gustatory processing in insular cortex
Lower state anxiety due to increased dopamine release in the substantia nigra pars compacta
Lower state anxiety due to attenuated noradrenergic arousal from LC alongside greater mPFC regulatory engagement
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. β-adrenergic receptors mediate noradrenergic arousal responses, with the locus coeruleus (LC) as a primary source and the medial prefrontal cortex (mPFC) providing regulatory control. In this vignette, β-adrenergic blockade reduces LC activity and sympathetic arousal while increasing mPFC engagement. Choice B is correct because it accurately reflects how blocking β-adrenergic receptors attenuates noradrenergic arousal from the LC while enhancing mPFC regulatory engagement, leading to lower anxiety. Choice A is incorrect because the antagonist reduces, not increases, LC activity. When analyzing adrenergic modulation, consider that β-blockers reduce peripheral and central arousal while potentially enhancing prefrontal regulatory capacity.
In a rodent lesion study, researchers produced excitotoxic lesions of the basolateral amygdala (BLA) in one group and sham surgery in another. After recovery, animals underwent cue-induced reinstatement of lever pressing for a previously extinguished sucrose reward. During reinstatement, in vivo microdialysis measured glutamate concentrations in the nucleus accumbens (NAc). BLA-lesioned animals showed blunted cue-induced increases in NAc glutamate and reduced reinstatement responding compared with sham animals, while baseline locomotion was similar. Which behavior change would be expected following the described brain structure damage and neurotransmitter change?
Increased cue-induced lever pressing due to greater NAc glutamate release after BLA lesion
Reduced cue-induced lever pressing due to decreased serotonin release in the hippocampus during extinction recall
Reduced cue-induced lever pressing due to diminished BLA-driven glutamatergic modulation of NAc during cue processing
Unchanged reinstatement responding because cue-induced relapse depends primarily on cerebellar Purkinje cell output
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. The basolateral amygdala (BLA) sends glutamatergic projections to the nucleus accumbens (NAc) that are crucial for cue-induced reward seeking. In this vignette, BLA lesions reduce glutamate release in the NAc during cue presentation, affecting reinstatement behavior. Choice B is correct because it accurately reflects how BLA damage diminishes glutamatergic modulation of the NAc during cue processing, leading to reduced cue-induced lever pressing. Choice A is incorrect because BLA lesions decrease, not increase, NAc glutamate release. When analyzing brain circuit disruptions, consider that damage to upstream structures (BLA) reduces neurotransmitter release in downstream targets (NAc), impairing associated behaviors.
A study evaluated the effect of acute opioid receptor activation on social pain. Forty participants were randomized to receive either a single dose of a $$-opioid receptor agonist or placebo before completing a task involving simulated social exclusion. The primary behavioral outcome was self-reported distress, and fMRI focused on dorsal anterior cingulate cortex (dACC) and anterior insula. Compared with placebo, the agonist group showed reduced dACC and anterior insula activation during exclusion and reported lower distress, without differences in general alertness. Which outcome is most consistent with the observed neurotransmitter effects?
Higher distress due to increased dACC activation driven by opioid receptor stimulation
Lower distress due to selective blockade of NMDA receptors in the hippocampus
Lower distress due to reduced dACC/anterior insula responses during exclusion following opioid receptor activation
No change in distress because opioid signaling primarily affects occipital cortex visual processing
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Opioid receptor activation modulates pain processing, including social pain, by affecting brain regions like the dACC and anterior insula. In this vignette, μ-opioid receptor activation reduces activity in these pain-processing regions during social exclusion. Choice B is correct because it accurately reflects how opioid receptor activation reduces dACC and anterior insula responses to social exclusion, leading to lower subjective distress. Choice A is incorrect because opioid receptor stimulation typically reduces, not increases, pain-related brain activation and distress. When analyzing opioid effects, remember that opioid receptor activation generally dampens both physical and social pain processing in overlapping neural circuits.
Researchers tested whether blocking D2 dopamine receptors alters effort-based decision-making. In a randomized crossover design, 30 adults received either a low dose of a D2 antagonist or placebo on separate days before completing a task in which they chose between a low-effort/low-reward option and a high-effort/high-reward option. fMRI focused on ventral striatum (including nucleus accumbens) during choice. Under the D2 antagonist, participants showed reduced ventral striatal BOLD response to high-reward cues and selected the high-effort option less frequently; subjective ratings of reward magnitude were unchanged. Which behavior change would be expected following the described neurotransmitter modulation?
Decreased selection of high-effort options due to increased serotonin signaling in the amygdala
Increased selection of high-effort options due to enhanced ventral striatal responsiveness to reward cues
No change in effort-based choices because D2 receptors primarily regulate hippocampal episodic memory encoding
Decreased selection of high-effort options due to reduced dopaminergic signaling in ventral striatum during reward anticipation
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Dopamine signaling through D2 receptors in the ventral striatum is crucial for motivation and effort-based decision-making. In this vignette, blocking D2 receptors reduces dopaminergic signaling in the ventral striatum during reward anticipation. Choice B is correct because it accurately reflects how D2 antagonism reduces ventral striatal responsiveness to reward cues, leading to decreased motivation for high-effort options. Choice D is incorrect because the observed effects are specifically due to reduced dopamine signaling, not increased serotonin, and occur in the ventral striatum, not amygdala. When analyzing dopamine effects on motivation, consider that D2 receptor blockade typically reduces reward-seeking behavior by dampening striatal reward processing.
A laboratory study measured cerebrospinal fluid (CSF) levels of gamma-aminobutyric acid (GABA) in 72 adults and assessed startle magnitude to unpredictable loud tones while participants viewed neutral images. Startle magnitude was recorded via orbicularis oculi electromyography. Functional MRI during the same session measured activity in the bed nucleus of the stria terminalis (BNST), a region implicated in sustained threat monitoring. Participants were stratified into Low, Medium, and High CSF GABA tertiles. Higher CSF GABA was associated with lower BNST activation and smaller startle responses, with no group differences in auditory acuity. Which outcome is most consistent with the observed neurotransmitter effects?
High CSF GABA predicts smaller startle by increasing acetylcholine release from the substantia nigra
High CSF GABA predicts unchanged BNST activation because startle is governed primarily by occipital cortex processing
High CSF GABA predicts increased BNST activation and larger startle due to enhanced excitatory tone
High CSF GABA predicts reduced BNST activation and smaller startle due to greater inhibitory signaling
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. GABA is the primary inhibitory neurotransmitter in the brain, reducing neural excitability in target regions. In this vignette, higher CSF GABA levels affect startle responses through inhibitory signaling in the BNST, a region involved in sustained threat monitoring. Choice B is correct because it accurately reflects how increased GABA produces greater inhibitory signaling, reducing BNST activation and consequently diminishing startle responses to unpredictable threats. Choice A is incorrect because GABA is inhibitory, not excitatory, so high levels would reduce rather than increase BNST activation. When analyzing GABA effects, remember that as an inhibitory neurotransmitter, higher levels typically reduce neural activity and associated behavioral responses.
Investigators examined 48 patients with focal bilateral hippocampal damage following an ischemic event and 48 matched controls. During PET imaging, participants completed a contextual fear-conditioning paradigm in which a neutral context was paired with an aversive sound. The primary behavioral outcome was context-specific freezing during a later test. PET quantification targeted hippocampus and amygdala and focused on norepinephrine (NE) release (indexed by displacement of an NE-sensitive radioligand) during acquisition. Patients with hippocampal damage showed preserved amygdala NE release during acquisition but reduced context-specific freezing at test compared with controls. Which statement best explains how the described brain structure influences behavior via neurotransmitter activity?
Reduced freezing is best explained by impaired basal ganglia dopamine signaling that prevents motor output of fear
The hippocampus directly generates NE release in the amygdala, so damage should abolish amygdala NE during acquisition
The amygdala is required for explicit recall of the context, so preserved amygdala NE should normalize context memory
The hippocampus is necessary for binding contextual cues to the amygdala-driven NE signal that supports later context-specific freezing
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. The hippocampus is crucial for contextual memory formation, binding environmental cues to emotional responses mediated by the amygdala. In this vignette, norepinephrine release in the amygdala signals threat, but the hippocampus is needed to associate this signal with specific contexts. Choice A is correct because it accurately reflects the hippocampus's role in binding contextual information to amygdala-driven fear responses, explaining why hippocampal damage impairs context-specific freezing despite preserved amygdala NE. Choice B is incorrect because the hippocampus doesn't directly generate NE in the amygdala; NE is released by locus coeruleus projections. When analyzing brain structure interactions, remember that the hippocampus provides contextual information that guides when amygdala-mediated responses should be expressed.
In a double-blind study, 60 healthy adults received either a single oral dose of a selective serotonin reuptake inhibitor (SSRI) or placebo 3 hours before completing a computerized go/no-go task during fMRI. The primary behavioral outcome was false alarms (responding on no-go trials), interpreted as reduced inhibitory control. fMRI analyses focused on ventromedial prefrontal cortex (vmPFC) and amygdala reactivity to negatively valenced distractor images presented between trials. The SSRI group showed reduced amygdala BOLD response to distractors and increased vmPFC–amygdala functional connectivity relative to placebo, while overall reaction time on go trials did not differ. Which behavior change is most consistent with these observed neurotransmitter and brain-structure effects?
Fewer false alarms driven by increased dopamine release in the nucleus accumbens
Fewer false alarms on no-go trials due to enhanced top-down regulation of amygdala responses by vmPFC
More false alarms on no-go trials due to heightened amygdala reactivity to negative distractors
No change in false alarms because serotonin primarily alters cerebellar timing rather than prefrontal control
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. SSRIs increase serotonin availability, which enhances prefrontal cortex regulation of emotional responses mediated by the amygdala. In this vignette, increased serotonin affects inhibitory control through enhanced vmPFC-amygdala connectivity. Choice B is correct because it accurately reflects how SSRIs enhance top-down regulation by the vmPFC over amygdala reactivity, leading to better inhibitory control and fewer false alarms. Choice A is incorrect because it suggests increased amygdala reactivity, which contradicts the observed reduced amygdala BOLD response under SSRI. When analyzing neurotransmitter effects, consider how increased serotonin typically enhances prefrontal regulatory control over subcortical emotional structures, improving behavioral inhibition.
In a lesion study, patients (n = 18) with bilateral hippocampal damage due to anoxia and matched controls (n = 18) completed a contextual fear learning task in which a distinct room context predicted an aversive noise. During learning, salivary cortisol was sampled as an index of hypothalamic–pituitary–adrenal (HPA) axis output, and startle responses were measured in the conditioned context versus a safe context. Controls showed increased cortisol and larger context-specific startle; hippocampal-damage patients showed preserved cortisol increases but reduced context-specific startle discrimination. How does the described brain structure influence behavior via neurotransmitter/hormone-linked activity, best explaining the dissociation?
The hippocampus directly mediates skeletal muscle startle reflexes via spinal acetylcholine, independent of context
The hippocampus is the primary generator of cortisol release, so hippocampal damage should eliminate cortisol responses entirely
The hippocampus supports encoding of contextual representations needed for discrimination, while HPA activation can occur without precise context mapping
The hippocampus increases startle by elevating dopamine in the nucleus accumbens, which is sufficient for context discrimination
Explanation
This question tests the understanding of the interaction between brain structures, neurotransmitters, and behavior. Neurotransmitters influence behavior by affecting brain structures, which mediate responses. In this vignette, cortisol and related hormones affect contextual fear through the hippocampus. Choice D is correct because it accurately reflects the role of the hippocampus in contextual encoding for discrimination, while HPA activation persists without it. Choice B is incorrect because it misinterprets the hippocampus as the primary cortisol generator, which does not explain preserved cortisol but reduced startle discrimination. When analyzing neurotransmitter effects, consider direct brain structure involvement and ensure conclusions align with observed data.